Ifex and Adriamycin pfs drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ifex (ifosfamide) and Adriamycin pfs (doxorubicin hydrochloride). Common drug interactions include pleural effusion among females and hypotension among males.

The phase IV clinical study analyzes what interactions people have when they take Ifex and Adriamycin pfs. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.

What is Ifex?

Ifex has active ingredients of ifosfamide. eHealthMe is studying from 829 Ifex users. Check the latest studies of Ifex.

What is Adriamycin pfs?

Adriamycin pfs has active ingredients of doxorubicin hydrochloride. eHealthMe is studying from 6,495 Adriamycin pfs users. Check the latest studies of Adriamycin pfs.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 01, 2026

26 people who take Ifex and Adriamycin pfs together, and have interactions are studied.

Ifex and Adriamycin pfs drug interactions.

What are the common drug interactions of Ifex and Adriamycin Pfs, by gender? *:

female:

  1. Pleural effusion (water on the lungs)
  2. Anxiety
  3. Bone disorder
  4. Bone erosion
  5. Cellulitis (infection under the skin)
  6. Chest wall mass
  7. Decreased interest
  8. Deformity (disfigurement)
  9. Emotional distress
  10. General physical health deterioration (weak health status)

male:

  1. Hypotension (abnormally low blood pressure)
  2. Pulmonary fibrosis (formation or development of excess fibrous connective tissue (fibrosis) in the lungs)
  3. White blood cell count abnormal
  4. Anaemia (lack of blood)
  5. Body temperature increased
  6. Cough
  7. Cystitis haemorrhagic (blood in the urine and painful voiding)
  8. Haematuria (presence of blood in urine)
  9. Haematuria present (presence of blood in urine due to trauma)
  10. Hypoxia (low oxygen in tissues)

What are the common drug interactions of Ifex and Adriamycin Pfs, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Anaemia (lack of blood)
  2. Cystitis haemorrhagic (blood in the urine and painful voiding)
  3. Febrile neutropenia (fever with reduced white blood cells)
  4. White blood cell count abnormal

20-29:

n/a

30-39:

  1. Blood chloride abnormal
  2. Blood potassium abnormal
  3. Blood sodium abnormal
  4. Dehydration (dryness resulting from the removal of water)
  5. Febrile neutropenia (fever with reduced white blood cells)
  6. Haematocrit
  7. Haemoglobin abnormal
  8. Mucosal inflammation (infection of mucous membrane)
  9. Pathological fracture (broken bone caused by disease)
  10. White blood cell count abnormal

40-49:

  1. Body temperature increased
  2. Dyspnoea (difficult or laboured respiration)
  3. Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)
  4. Metastases to lung (cancer spreads to lung)
  5. Mucosal inflammation (infection of mucous membrane)
  6. Neutrophil count abnormal (abnormal number of neutrophil a type of blood cell)
  7. Pharyngolaryngeal pain
  8. Pleural effusion (water on the lungs)
  9. Pulmonary embolism (blockage of the main artery of the lung)
  10. Respiratory rate increased (excess breathing rate/min)

50-59:

  1. Hypotension (abnormally low blood pressure)
  2. Pulmonary fibrosis (formation or development of excess fibrous connective tissue (fibrosis) in the lungs)
  3. Pyrexia (fever)
  4. Sepsis (a severe blood infection that can lead to organ failure and death)
  5. Neutropenia (an abnormally low number of neutrophils)
  6. Pulmonary embolism (blockage of the main artery of the lung)
  7. Acute respiratory distress syndrome
  8. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  9. Pneumonia fungal
  10. Cough

60+:

  1. Anxiety
  2. Bone disorder
  3. Impaired healing
  4. Metastases to bone (cancer spreads to bone)
  5. Pain
  6. Pleural effusion (water on the lungs)
  7. Sinusitis (inflammation of sinus)
  8. Tooth infection
  9. Pulmonary mass
  10. Tooth extraction

What are the existing conditions these people have? *

  1. Leiomyosarcoma (a very rare soft tissue sarcoma (cancer) that grows in muscle tissue): 10 people, 38.46%

* Approximation only. Some reports may have incomplete information.

Do you take Ifex and Adriamycin pfs?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ifex and Adriamycin pfs:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ifex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Adriamycin pfs:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ifex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Adriamycin pfs and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ifosfamide and doxorubicin hydrochloride (the active ingredients of Ifex and Adriamycin pfs, respectively), and Ifex and Adriamycin pfs (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: